Literature DB >> 16763475

The coagulopathy of trauma versus disseminated intravascular coagulation.

John R Hess1, Jeffrey H Lawson.   

Abstract

The coagulopathy of trauma is a syndrome of non-surgical bleeding from mucosal lesions, serosal surfaces, and wound and vascular access sites associated with serious injury, hypothermia, acidosis, hemodilution, and occasionally with classic disseminated intravascular coagulation (DIC). It can be largely explained by the effects of cold on platelet function, the effect of pH on coagulation factor activity, and the dilutional effects of resuscitation fluids and conventional blood products. DIC occurs acutely after trauma when brain, fat, amniotic fluid, or other strong thromboplastins enter the circulation. It occurs subacutely when endothelial inflammation or failure reduces clearing of activated coagulation factors allowing microthrombi to cause secondary injury. The coagulopathy of trauma should be anticipated in massive transfusion situations. Early treatment with plasma can delay its onset. The underlying mechanisms should be confirmed with laboratory testing.

Entities:  

Mesh:

Year:  2006        PMID: 16763475     DOI: 10.1097/01.ta.0000199545.06536.22

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  29 in total

1.  Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient.

Authors:  Timothy C Nunez; Pampee P Young; John B Holcomb; Bryan A Cotton
Journal:  J Trauma       Date:  2010-06

Review 2.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

3.  Trends in transfusion of trauma victims--evaluation of changes in clinical practice.

Authors:  Anders R Nakstad; Nils O Skaga; Johan Pillgram-Larsen; Berit Gran; Hans E Heier
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-11       Impact factor: 2.953

4.  Sonic Estimation of Elasticity via Resonance: A New Method of Assessing Hemostasis.

Authors:  F Scott Corey; William F Walker
Journal:  Ann Biomed Eng       Date:  2015-09-23       Impact factor: 3.934

5.  High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.

Authors:  D H Lee; B K Lee; S M Noh; Y S Cho
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-18       Impact factor: 3.693

Review 6.  TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy.

Authors:  K G Mann; K Freeman
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

7.  Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital.

Authors:  Philip C Spinella; Jeremy G Perkins; Kurt W Grathwohl; Thomas Repine; Alec C Beekley; James Sebesta; Donald Jenkins; Kenneth Azarow; John B Holcomb
Journal:  World J Surg       Date:  2007-11-09       Impact factor: 3.352

8.  Management of bleeding following major trauma: an updated European guideline.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

Review 9.  Resuscitation and transfusion principles for traumatic hemorrhagic shock.

Authors:  Philip C Spinella; John B Holcomb
Journal:  Blood Rev       Date:  2009-08-19       Impact factor: 8.250

Review 10.  Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.